These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 11256242

  • 1. [Administration of granulocyte colony-stimulating factor in patients infected with human immunodeficiency virus and prolonged neutropenia].
    von Wichmann MA, Camino X, Txoperena G, Arrizabalaga J, Rodríguez-Arrondo F, Iribarren JA.
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):19-23. PubMed ID: 11256242
    [Abstract] [Full Text] [Related]

  • 2. [Prevention and treatment of febrile neutropenia].
    Montemurro F, Gallicchio M, Aglietta M.
    Tumori; 1997 Jan; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lhéritier V, Fiere D, Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).
    Hematol J; 2004 Jan; 5(5):384-94. PubMed ID: 15448664
    [Abstract] [Full Text] [Related]

  • 4. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus.
    Ambati BK, Perlman DC, Salomon N.
    Int J Infect Dis; 2008 Dec; 3(2):70-5. PubMed ID: 10225983
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L.
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [Abstract] [Full Text] [Related]

  • 7. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G.
    N Engl J Med; 1991 Jul 18; 325(3):164-70. PubMed ID: 1711156
    [Abstract] [Full Text] [Related]

  • 8. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.
    Kuritzkes DR, Parenti D, Ward DJ, Rachlis A, Wong RJ, Mallon KP, Rich WJ, Jacobson MA.
    AIDS; 1998 Jan 01; 12(1):65-74. PubMed ID: 9456256
    [Abstract] [Full Text] [Related]

  • 9. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T, Burney IA, Kakepoto GN, Khurshid M, Salam A, Smego RA.
    J Pak Med Assoc; 2002 May 01; 52(5):206-10. PubMed ID: 12174492
    [Abstract] [Full Text] [Related]

  • 10. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 01; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF, Krailo M, Chen Z, Feusner J.
    Pediatr Blood Cancer; 2005 Sep 01; 45(3):274-80. PubMed ID: 15806544
    [Abstract] [Full Text] [Related]

  • 12. The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals.
    Nielsen SD, Sørensen TU, Aladdin H, Ersbøll AK, Mathiesen L, Ullum H, Gerstoft J, Nielsen JO, Pedersen BK.
    Scand J Immunol; 2000 Sep 01; 52(3):298-303. PubMed ID: 10972907
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of Granulocyte Colony-Stimulating Factor in a Neutropenic HIV-Infected Patient on Clozapine.
    Elmore H, Lewin J, Bradley M, Sinkman A.
    Psychosomatics; 2016 Sep 01; 57(6):651-654. PubMed ID: 27720385
    [No Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Ravaud A, Chevreau C, Cany L, Houyau P, Dohollou N, Roché H, Soubeyran P, Bonichon F, Mihura J, Eghbali H, Tabah I, Bui BN.
    J Clin Oncol; 1998 Sep 01; 16(9):2930-6. PubMed ID: 9738560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.